Cargando…
65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES
BACKGROUND: Brain metastasis (BrM) patients treated with surgery and radiotherapy frequently experience local recurrence (LR), leptomeningeal metastasis (LM), and poor overall survival (OS). We sought to correlate the presence of invasive or circumscribed histopathological growth pattern, observed i...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401331/ http://dx.doi.org/10.1093/noajnl/vdaa073.052 |
_version_ | 1783566540244779008 |
---|---|
author | Dankner, Matthew Caron, Maxime Al-Saadi, Tariq Yu, WenQing Ouellet, Veronique Uyen Le, Phuong Ezzeddine, Rima Neubarth, Noah Savage, Paul Zuo, Dongmei Altoukhi, Huda Bourque, Guillaume Ragoussis, Jiannis Diaz, Roberto Park, Morag Guiot, Marie-Christine Lam, Stephanie Petrecca, Kevin Siegel, Peter M |
author_facet | Dankner, Matthew Caron, Maxime Al-Saadi, Tariq Yu, WenQing Ouellet, Veronique Uyen Le, Phuong Ezzeddine, Rima Neubarth, Noah Savage, Paul Zuo, Dongmei Altoukhi, Huda Bourque, Guillaume Ragoussis, Jiannis Diaz, Roberto Park, Morag Guiot, Marie-Christine Lam, Stephanie Petrecca, Kevin Siegel, Peter M |
author_sort | Dankner, Matthew |
collection | PubMed |
description | BACKGROUND: Brain metastasis (BrM) patients treated with surgery and radiotherapy frequently experience local recurrence (LR), leptomeningeal metastasis (LM), and poor overall survival (OS). We sought to correlate the presence of invasive or circumscribed histopathological growth pattern, observed in the BrM lesion and surrounding brain, with these outcomes, and to study molecular mediators of parenchymal invasion. METHODS: We assessed the HGP of H&E-stained slides from 164 surgically resected BrM from 147 patients. HGP was correlated with incidence of LR, LM and OS. Single-cell RNA sequencing (scRNAseq) was performed on three invasive HGP patients, sampling the metastasis center (MC) and surrounding brain (SB) outside of the contrast-enhancing region. Orthotopic patient-derived xenograft models (OPDX) were established from N=30 brain metastasis via intracranial propagation. RESULTS: 56/164 BrM specimens (34%) showed a circumscribed growth pattern between the tumor and adjacent brain (cHGP) while 108/164 (66%) showed significant invasion of tumor lobules or single cells into the brain parenchyma (iHGP). iHGP was associated with LR, LM and shortened OS in BrM patients. OPDX models of BrM retain features of patient BrM, including HGP. scRNAseq identified abundant cancer cells in SB that overexpressed a number of genes involved in cell survival, invasion and metastasis compared to matched cancer cells in MC. Validation of these targets with immunohistochemistry in patient and OPDX tissues revealed cold-inducible RNA binding protein (CIRBP) overexpression in iHGP patient and OPDX BrM. Modulation of CIRBP expression in OPDX and cell line models of iHGP BrM delayed BrM progression and extended OS. CONCLUSION: iHGP is a poor prognostic indicator in patients with surgically resected BrM, establishing HGP as an important prognostic factor that should be considered by clinicians treating BrM patients. We identify CIRBP as a functional mediator of this process. |
format | Online Article Text |
id | pubmed-7401331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-74013312020-08-06 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES Dankner, Matthew Caron, Maxime Al-Saadi, Tariq Yu, WenQing Ouellet, Veronique Uyen Le, Phuong Ezzeddine, Rima Neubarth, Noah Savage, Paul Zuo, Dongmei Altoukhi, Huda Bourque, Guillaume Ragoussis, Jiannis Diaz, Roberto Park, Morag Guiot, Marie-Christine Lam, Stephanie Petrecca, Kevin Siegel, Peter M Neurooncol Adv Supplement Abstracts BACKGROUND: Brain metastasis (BrM) patients treated with surgery and radiotherapy frequently experience local recurrence (LR), leptomeningeal metastasis (LM), and poor overall survival (OS). We sought to correlate the presence of invasive or circumscribed histopathological growth pattern, observed in the BrM lesion and surrounding brain, with these outcomes, and to study molecular mediators of parenchymal invasion. METHODS: We assessed the HGP of H&E-stained slides from 164 surgically resected BrM from 147 patients. HGP was correlated with incidence of LR, LM and OS. Single-cell RNA sequencing (scRNAseq) was performed on three invasive HGP patients, sampling the metastasis center (MC) and surrounding brain (SB) outside of the contrast-enhancing region. Orthotopic patient-derived xenograft models (OPDX) were established from N=30 brain metastasis via intracranial propagation. RESULTS: 56/164 BrM specimens (34%) showed a circumscribed growth pattern between the tumor and adjacent brain (cHGP) while 108/164 (66%) showed significant invasion of tumor lobules or single cells into the brain parenchyma (iHGP). iHGP was associated with LR, LM and shortened OS in BrM patients. OPDX models of BrM retain features of patient BrM, including HGP. scRNAseq identified abundant cancer cells in SB that overexpressed a number of genes involved in cell survival, invasion and metastasis compared to matched cancer cells in MC. Validation of these targets with immunohistochemistry in patient and OPDX tissues revealed cold-inducible RNA binding protein (CIRBP) overexpression in iHGP patient and OPDX BrM. Modulation of CIRBP expression in OPDX and cell line models of iHGP BrM delayed BrM progression and extended OS. CONCLUSION: iHGP is a poor prognostic indicator in patients with surgically resected BrM, establishing HGP as an important prognostic factor that should be considered by clinicians treating BrM patients. We identify CIRBP as a functional mediator of this process. Oxford University Press 2020-08-04 /pmc/articles/PMC7401331/ http://dx.doi.org/10.1093/noajnl/vdaa073.052 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Supplement Abstracts Dankner, Matthew Caron, Maxime Al-Saadi, Tariq Yu, WenQing Ouellet, Veronique Uyen Le, Phuong Ezzeddine, Rima Neubarth, Noah Savage, Paul Zuo, Dongmei Altoukhi, Huda Bourque, Guillaume Ragoussis, Jiannis Diaz, Roberto Park, Morag Guiot, Marie-Christine Lam, Stephanie Petrecca, Kevin Siegel, Peter M 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES |
title | 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES |
title_full | 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES |
title_fullStr | 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES |
title_full_unstemmed | 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES |
title_short | 65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES |
title_sort | 65. invasive histopathology drives poor outcomes in surgically resected brain metastases |
topic | Supplement Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401331/ http://dx.doi.org/10.1093/noajnl/vdaa073.052 |
work_keys_str_mv | AT danknermatthew 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT caronmaxime 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT alsaaditariq 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT yuwenqing 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT ouelletveronique 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT uyenlephuong 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT ezzeddinerima 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT neubarthnoah 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT savagepaul 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT zuodongmei 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT altoukhihuda 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT bourqueguillaume 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT ragoussisjiannis 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT diazroberto 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT parkmorag 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT guiotmariechristine 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT lamstephanie 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT petreccakevin 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases AT siegelpeterm 65invasivehistopathologydrivespooroutcomesinsurgicallyresectedbrainmetastases |